Takehiko Ohba

1PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 11, 2018
ALK-Positive Squamous Cell Carcinoma Dramatically Responded to Alectinib.

Ray Sagawa, Takehiko Ohba, Eisaku Ito

Pageof 1

Frequent Collaborators

1 joint publications

Ray Sagawa

1 joint publications

Eisaku Ito

1 joint publications

Susumu Isogai